You are here
- Home
- Lung Cancer Chemotherapy
Lung Cancer Chemotherapy
- Feasibility study of in vitro drug sensitivity assay of advanced non-small cell lung adenocarcinomasEmoke Papp, Anita Steib, Elhusseiny MM Abdelwahab, Judit Meggyes-Rapp, Laszlo Jakab, Gabor Smuk, Erzsebet Schlegl, Judit Moldvay, Veronika Sárosi, Judit E PongraczBMJ Open Respiratory Research Jun 2020, 7 (1) e000505; DOI: 10.1136/bmjresp-2019-000505
- Impact on quality of life from multimodality treatment for lung cancer: a randomised controlled feasibility trial of surgery versus no surgery as part of multimodality treatment in potentially resectable stage III-N2 NSCLC (the PIONEER trial)Sally Taylor, Janelle Yorke, Selina Tsim, Neal Navani, David Baldwin, Ian Woolhouse, John Edwards, Seamus Grundy, Jonathan Robson, Sarah Rhodes, Fabio Gomes, Fiona Blackhall, Corinne Faivre-Finn, Matthew EvisonBMJ Open Respiratory Research Jul 2021, 8 (1) e000846; DOI: 10.1136/bmjresp-2020-000846
- Reliable EGFR mutation testing in ultrasound-guided supraclavicular lymph node fine-needle aspirates: a cohort study with diagnostic performance analysisAmir Awwad, Sandeep Tiwari, Vishakha Sovani, David R Baldwin, Maruti KumaranBMJ Open Respiratory Research Jul 2015, 2 (1) e000075; DOI: 10.1136/bmjresp-2014-000075
- An unblinded, randomised phase II study of platinum-based chemotherapy with vitamin B12 and folic acid supplementation in the treatment of lung cancer with plasma homocysteine blood levels as a biomarker of severe neutropenic toxicityA R Minchom, K Saksornchai, J Bhosle, R Gunapala, M Puglisi, S K Lu, K Nimako, J Coward, K C Yu, P Bordi, S Popat, M E R O'BrienBMJ Open Respiratory Research Dec 2014, 1 (1) e000061; DOI: 10.1136/bmjresp-2014-000061
- BMJ Open Respiratory Research
- Cough (3)
- Critical care (8)
- Cystic fibrosis (3)
- Lung cancer (9)
- Sleep (2)
- Thoracic surgery (1)
- Tuberculosis (2)